Whoop has landed in hot water with the U.S. Food and Drug Administration (FDA) over one of its most eyebrow-raising features: Blood Pressure Insights.
According to a formal warning letter issued to the company, the FDA believes the feature amounts to an unapproved medical device, and says Whoop is marketing it without the proper regulatory clearance.
